Qube Research & Technologies Ltd - CORMEDIX INC ownership

CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C308. A total of 67 filers reported holding CORMEDIX INC in Q4 2022. The put-call ratio across all filers is 4.42 and the average weighting 1.4%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CORMEDIX INC
ValueSharesWeighting
Q1 2023$53,563
-64.4%
12,938
-63.7%
0.00%
-100.0%
Q4 2022$150,422
+97.9%
35,645
+32.2%
0.00%
Q3 2022$76,000
-39.7%
26,960
-13.9%
0.00%
-100.0%
Q2 2022$126,000
-36.0%
31,300
+8.8%
0.00%
-50.0%
Q2 2021$197,00028,7710.00%
Other shareholders
CORMEDIX INC shareholders Q4 2022
NameSharesValueWeighting ↓
Spinnaker Capital LLC 175,384$816,0001.09%
PLANNING DIRECTIONS INC 50,000$232,0000.17%
HGI Capital Management, LLC 52,256$243,0000.10%
Elliott Investment Management L.P. 1,550,523$7,210,0000.05%
RIVERSEDGE ADVISORS, LLC 14,259$66,0000.02%
Cresset Asset Management, LLC 329,796$1,534,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 170,300$792,0000.02%
Steward Partners Investment Advisory, LLC 168,065$782,0000.01%
Austin Private Wealth, LLC 10,480$49,0000.01%
Avestar Capital, LLC 10,000$47,0000.01%
View complete list of CORMEDIX INC shareholders